Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced no…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced no…
この記事を読む
Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. Sanchis-Borja M et al Lung Canc…
この記事を読む
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma. Domblides C et al. J Thorac Oncol. 2020 May;15(5…
この記事を読む
Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A…
この記事を読む
Cachexia – sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients rece…
この記事を読む
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from …
この記事を読む
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. A…
この記事を読む
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From th…
この記事を読む
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epide…
この記事を読む
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metast…